{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:23:18Z","timestamp":1793049798019,"version":"4.5.0"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/nrgastro.2017.101","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T05:57:59Z","timestamp":1504072679000},"page":"596-611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD"],"prefix":"10.1038","volume":"14","author":[{"given":"Sophie","family":"Van Welden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Selfridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Hindryckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"BFnrgastro2017101_CR1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI200421086","volume":"114","author":"J Karhausen","year":"2004","unstructured":"Karhausen, J. et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114, 1098\u20131106 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/labinvest.2010.37","volume":"90","author":"P Hindryckx","year":"2010","unstructured":"Hindryckx, P. et al. Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury. Lab Invest. 90, 566\u2013576 (2010).","journal-title":"Lab Invest."},{"key":"BFnrgastro2017101_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/jcp.56.3.209","volume":"56","author":"A Giatromanolaki","year":"2003","unstructured":"Giatromanolaki, A. et al. Hypoxia inducible factor 1\u03b1 and 2\u03b1 overexpression in inflammatory bowel disease. J. Clin. Pathol. 56, 209\u2013213 (2003).","journal-title":"J. Clin. Pathol."},{"key":"BFnrgastro2017101_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/gut.42.4.477","volume":"42","author":"S Schreiber","year":"1998","unstructured":"Schreiber, S., Nikolaus, S. & Hampe, J. Activation of nuclear factor \u03baB inflammatory bowel disease. Gut 42, 477\u2013484 (1998).","journal-title":"Gut"},{"key":"BFnrgastro2017101_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3892\/etm.2016.3030","volume":"11","author":"C Xu","year":"2016","unstructured":"Xu, C. & Dong, W. Role of hypoxia-inducible factor-1\u03b1 in pathogenesis and disease evaluation of ulcerative colitis. Exp. Ther. Med. 11, 1330\u20131334 (2016).","journal-title":"Exp. Ther. Med."},{"key":"BFnrgastro2017101_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00109-007-0277-z","volume":"85","author":"CT Taylor","year":"2007","unstructured":"Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. (Berl.) 85, 1295\u20131300 (2007).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrgastro2017101_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12013-013-9611-y","volume":"67","author":"EM Fisher","year":"2013","unstructured":"Fisher, E. M., Khan, M., Salisbury, R. & Kuppusamy, P. Noninvasive monitoring of small intestinal oxygen in a rat model of chronic mesenteric ischemia. Cell Biochem. Biophys. 67, 451\u2013459 (2013).","journal-title":"Cell Biochem. Biophys."},{"key":"BFnrgastro2017101_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40348-016-0041-y","volume":"3","author":"NE Zeitouni","year":"2016","unstructured":"Zeitouni, N. E., Chotikatum, S., von Kockritz-Blickwede, M. & Naim, H. Y. The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens. Mol. Cell Pediatr. 3, 14 (2016).","journal-title":"Mol. Cell Pediatr."},{"key":"BFnrgastro2017101_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2013.11.020","volume":"40","author":"EL Campbell","year":"2014","unstructured":"Campbell, E. L. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40, 66\u201377 (2014).","journal-title":"Immunity"},{"key":"BFnrgastro2017101_CR10","doi-asserted-by":"publisher","first-page":"H1791","DOI":"10.1152\/ajpheart.00552.2003","volume":"285","author":"OA Hatoum","year":"2003","unstructured":"Hatoum, O. A., Miura, H. & Binion, D. G. The vascular contribution in the pathogenesis of inflammatory bowel disease. Am. J. Physiol. Heart Circ. Physiol. 285, H1791\u2013H1796 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrgastro2017101_CR11","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic\u2013helix\u2013loop\u2013helix\u2013PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510\u20135514 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464\u2013468 (2001).","journal-title":"Science"},{"key":"BFnrgastro2017101_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u2013275 (1999).","journal-title":"Nature"},{"key":"BFnrgastro2017101_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3892\/ijmm.2015.2079","volume":"35","author":"J Biddlestone","year":"2015","unstructured":"Biddlestone, J., Bandarra, D. & Rocha, S. The role of hypoxia in inflammatory disease (review). Int. J. Mol. Med. 35, 859\u2013869 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"BFnrgastro2017101_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrm1366","volume":"5","author":"CJ Schofield","year":"2004","unstructured":"Schofield, C. J. & Ratcliffe, P. J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343\u2013354 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrgastro2017101_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20070389","volume":"405","author":"GL Semenza","year":"2007","unstructured":"Semenza, G. L. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem. J. 405, 1\u20139 (2007).","journal-title":"Biochem. J."},{"key":"BFnrgastro2017101_CR17","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1093\/nar\/gkp1205","volume":"38","author":"A Ortiz-Barahona","year":"2010","unstructured":"Ortiz-Barahona, A., Villar, D., Pescador, N., Amigo, J. & del Peso, L. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res. 38, 2332\u20132345 (2010).","journal-title":"Nucleic Acids Res."},{"key":"BFnrgastro2017101_CR18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1039\/b701676j","volume":"37","author":"R Chowdhury","year":"2008","unstructured":"Chowdhury, R., Hardy, A. & Schofield, C. J. The human oxygen sensing machinery and its manipulation. Chem. Soc. Rev. 37, 1308\u20131319 (2008).","journal-title":"Chem. Soc. Rev."},{"key":"BFnrgastro2017101_CR19","doi-asserted-by":"publisher","first-page":"23482","DOI":"10.1074\/jbc.M601719200","volume":"281","author":"DP Stiehl","year":"2006","unstructured":"Stiehl, D. P. et al. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482\u201323491 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR20","first-page":"1425","volume":"54","author":"AC Koong","year":"1994","unstructured":"Koong, A. C., Chen, E. Y. & Giaccia, A. J. Hypoxia causes the activation of nuclear factor \u03baB through the phosphorylation of I\u03baB\u03b1 on tyrosine residues. Cancer Res. 54, 1425\u20131430 (1994).","journal-title":"Cancer Res."},{"key":"BFnrgastro2017101_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1749-6632.2009.05024.x","volume":"1177","author":"CT Taylor","year":"2009","unstructured":"Taylor, C. T. & Cummins, E. P. The role of NF-\u03baB in hypoxia-induced gene expression. Ann. NY Acad. Sci. 1177, 178\u2013184 (2009).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrgastro2017101_CR22","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1089\/ars.2008.2400","volume":"11","author":"KM Oliver","year":"2009","unstructured":"Oliver, K. M. et al. Hypoxia activates NF-\u03baB-dependent gene expression through the canonical signaling pathway. Antioxid. Redox Signal 11, 2057\u20132064 (2009).","journal-title":"Antioxid. Redox Signal"},{"key":"BFnrgastro2017101_CR23","doi-asserted-by":"publisher","first-page":"18154","DOI":"10.1073\/pnas.0602235103","volume":"103","author":"EP Cummins","year":"2006","unstructured":"Cummins, E. P. et al. Prolyl hydroxylase-1 negatively regulates I\u03baB kinase-\u03b2, giving insight into hypoxia-induced NF\u03baB activity. Proc. Natl Acad. Sci. USA 103, 18154\u201318159 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature10507","volume":"479","author":"Y Takeda","year":"2011","unstructured":"Takeda, Y. et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479, 122\u2013126 (2011).","journal-title":"Nature"},{"key":"BFnrgastro2017101_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1053\/j.gastro.2009.09.049","volume":"138","author":"J Xue","year":"2010","unstructured":"Xue, J. et al. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKK\u03b2 independent of hydroxylase activity. Gastroenterology 138, 606\u2013615 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR26","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1128\/MCB.00273-13","volume":"33","author":"J Fu","year":"2013","unstructured":"Fu, J. & Taubman, M. B. EGLN3 inhibition of NF-\u03baB is mediated by prolyl hydroxylase-independent inhibition of I\u03baB kinase \u03b3 ubiquitination. Mol. Cell. Biol. 33, 3050\u20133061 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/01.HYP.38.1.48","volume":"38","author":"M Aoki","year":"2001","unstructured":"Aoki, M. et al. Endothelial apoptosis induced by oxidative stress through activation of NF-\u03baB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38, 48\u201355 (2001).","journal-title":"Hypertension"},{"key":"BFnrgastro2017101_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0008-6363(98)00285-5","volume":"42","author":"H Matsui","year":"1999","unstructured":"Matsui, H. et al. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-\u03baB and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42, 104\u2013112 (1999).","journal-title":"Cardiovasc. Res."},{"key":"BFnrgastro2017101_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.4049\/jimmunol.1002256","volume":"186","author":"SF Fitzpatrick","year":"2011","unstructured":"Fitzpatrick, S. F. et al. An intact canonical NF-\u03baB pathway is required for inflammatory gene expression in response to hypoxia. J. Immunol. 186, 1091\u20131096 (2011).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20040624","volume":"201","author":"SR Walmsley","year":"2005","unstructured":"Walmsley, S. R. et al. Hypoxia-induced neutrophil survival is mediated by HIF-1\u03b1-dependent NF-\u03baB activity. J. Exp. Med. 201, 105\u2013115 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2017101_CR31","doi-asserted-by":"publisher","first-page":"14767","DOI":"10.1073\/pnas.0606877103","volume":"103","author":"ME Cockman","year":"2006","unstructured":"Cockman, M. E. et al. Posttranslational hydroxylation of ankyrin repeats in I\u03baB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl Acad. Sci. USA 103, 14767\u201314772 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.ATV.0000258979.92828.bc","volume":"27","author":"S Bonello","year":"2007","unstructured":"Bonello, S. et al. Reactive oxygen species activate the HIF-1\u03b1 promoter via a functional NF\u03baB site. Arterioscler. Thromb. Vasc. Biol. 27, 755\u2013761 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrgastro2017101_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1042\/BJ20080476","volume":"412","author":"P van Uden","year":"2008","unstructured":"van Uden, P., Kenneth, N. S. & Rocha, S. Regulation of hypoxia-inducible factor-1\u03b1 by NF-\u03baB. Biochem. J. 412, 477\u2013484 (2008).","journal-title":"Biochem. J."},{"key":"BFnrgastro2017101_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06905","volume":"453","author":"J Rius","year":"2008","unstructured":"Rius, J. et al. NF-\u03baB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1\u03b1. Nature 453, 807\u2013811 (2008).","journal-title":"Nature"},{"key":"BFnrgastro2017101_CR35","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1074\/jbc.M409987200","volume":"280","author":"CP Bracken","year":"2005","unstructured":"Bracken, C. P., Whitelaw, M. L. & Peet, D. J. Activity of hypoxia-inducible factor 2\u03b1 is regulated by association with the NF-\u03baB essential modulator. J. Biol. Chem. 280, 14240\u201314251 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1042\/BJ20051839","volume":"396","author":"S Frede","year":"2006","unstructured":"Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44\/42 MAPK and NF-\u03baB. Biochem. J. 396, 517\u2013527 (2006).","journal-title":"Biochem. J."},{"key":"BFnrgastro2017101_CR37","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1091\/mbc.e02-09-0598","volume":"14","author":"J Zhou","year":"2003","unstructured":"Zhou, J., Schmid, T. & Brune, B. Tumor necrosis factor-\u03b1 causes accumulation of a ubiquitinated form of hypoxia inducible factor-1\u03b1 through a nuclear factor-\u03baB-dependent pathway. Mol. Biol. Cell 14, 2216\u20132225 (2003).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrgastro2017101_CR38","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1091\/mbc.e07-02-0182","volume":"19","author":"J Kim","year":"2008","unstructured":"Kim, J. et al. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1\u03b1 expression through a Rac1-dependent NF-\u03baB pathway. Mol. Biol. Cell 19, 433\u2013444 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrgastro2017101_CR39","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1182\/blood-2007-10-115758","volume":"111","author":"M Scortegagna","year":"2008","unstructured":"Scortegagna, M. et al. HIF-1\u03b1 regulates epithelial inflammation by cell autonomous NF\u03baB activation and paracrine stromal remodeling. Blood 111, 3343\u20133354 (2008).","journal-title":"Blood"},{"key":"BFnrgastro2017101_CR40","doi-asserted-by":"publisher","first-page":"19447","DOI":"10.1074\/jbc.274.27.19447","volume":"274","author":"CT Taylor","year":"1999","unstructured":"Taylor, C. T., Fueki, N., Agah, A., Hershberg, R. M. & Colgan, S. P. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-\u03b1. J. Biol. Chem. 274, 19447\u201319454 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0016-5085(98)70579-7","volume":"114","author":"CT Taylor","year":"1998","unstructured":"Taylor, C. T., Dzus, A. L. & Colgan, S. P. Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 114, 657\u2013668 (1998).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR42","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.1073\/pnas.0401339101","volume":"101","author":"T Kong","year":"2004","unstructured":"Kong, T., Eltzschig, H. K., Karhausen, J., Colgan, S. P. & Shelley, C. S. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of \u03b22 integrin gene expression. Proc. Natl Acad. Sci. USA 101, 10440\u201310445 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0014-5793(95)00986-J","volume":"372","author":"S Hannah","year":"1995","unstructured":"Hannah, S. et al. Hypoxia prolongs neutrophil survival in vitro. FEBS Lett. 372, 233\u2013237 (1995).","journal-title":"FEBS Lett."},{"key":"BFnrgastro2017101_CR44","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1182\/blood-2002-02-0454","volume":"100","author":"KI Mecklenburgh","year":"2002","unstructured":"Mecklenburgh, K. I. et al. Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood 100, 3008\u20133016 (2002).","journal-title":"Blood"},{"key":"BFnrgastro2017101_CR45","doi-asserted-by":"publisher","first-page":"13903","DOI":"10.1073\/pnas.94.25.13903","volume":"94","author":"JK Yun","year":"1997","unstructured":"Yun, J. K. et al. Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc. Natl Acad. Sci. USA 94, 13903\u201313908 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR46","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/eji.201142053","volume":"42","author":"T Kohler","year":"2012","unstructured":"Kohler, T., Reizis, B., Johnson, R. S., Weighardt, H. & Forster, I. Influence of hypoxia-inducible factor 1\u03b1 on dendritic cell differentiation and migration. Eur. J. Immunol. 42, 1226\u20131236 (2012).","journal-title":"Eur. J. Immunol."},{"key":"BFnrgastro2017101_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.imbio.2012.02.002","volume":"218","author":"F Blengio","year":"2013","unstructured":"Blengio, F. et al. The hypoxic environment reprograms the cytokine\/chemokine expression profile of human mature dendritic cells. Immunobiology 218, 76\u201389 (2013).","journal-title":"Immunobiology"},{"key":"BFnrgastro2017101_CR48","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1182\/blood-2010-06-292136","volume":"117","author":"MC Bosco","year":"2011","unstructured":"Bosco, M. C. et al. Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117, 2625\u20132639 (2011).","journal-title":"Blood"},{"key":"BFnrgastro2017101_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12967-014-0293-z","volume":"12","author":"M Genua","year":"2014","unstructured":"Genua, M., Rutella, S., Correale, C. & Danese, S. The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis. J. Transl Med. 12, 293 (2014).","journal-title":"J. Transl Med."},{"key":"BFnrgastro2017101_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12291-013-0345-9","volume":"29","author":"KP Mishra","year":"2014","unstructured":"Mishra, K. P., Jain, S., Ganju, L. & Singh, S. B. Hypoxic stress induced TREM-1 and inflammatory chemokines in human peripheral blood mononuclear cells. Indian J. Clin. Biochem. 29, 133\u2013138 (2014).","journal-title":"Indian J. Clin. Biochem."},{"key":"BFnrgastro2017101_CR51","doi-asserted-by":"publisher","first-page":"C866","DOI":"10.1152\/ajpcell.1993.264.4.C866","volume":"264","author":"C Michiels","year":"1993","unstructured":"Michiels, C., Arnould, T., Knott, I., Dieu, M. & Remacle, J. Stimulation of prostaglandin synthesis by human endothelial cells exposed to hypoxia. Am. J. Physiol. 264, C866\u2013C874 (1993).","journal-title":"Am. J. Physiol."},{"key":"BFnrgastro2017101_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-4889(00)00041-0","volume":"1497","author":"C Michiels","year":"2000","unstructured":"Michiels, C., Arnould, T. & Remacle, J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim. Biophys. Acta 1497, 1\u201310 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrgastro2017101_CR53","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1172\/JCI114540","volume":"85","author":"S Ogawa","year":"1990","unstructured":"Ogawa, S. et al. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J. Clin. Invest. 85, 1090\u20131098 (1990).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR54","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843\u2013845 (1992).","journal-title":"Nature"},{"key":"BFnrgastro2017101_CR55","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","volume":"136","author":"F Scaldaferri","year":"2009","unstructured":"Scaldaferri, F. et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136, 585\u2013595.e5 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR56","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.193.9.1027","volume":"193","author":"GT Furuta","year":"2001","unstructured":"Furuta, G. T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027\u20131034 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2017101_CR57","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1084\/jem.184.3.1003","volume":"184","author":"SP Colgan","year":"1996","unstructured":"Colgan, S. P., Dzus, A. L. & Parkos, C. A. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration. J. Exp. Med. 184, 1003\u20131015 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2017101_CR58","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI0215337","volume":"110","author":"K Synnestvedt","year":"2002","unstructured":"Synnestvedt, K. et al. Ecto-5\u2032-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993\u20131002 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR59","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/jcb.20947","volume":"99","author":"NA Louis","year":"2006","unstructured":"Louis, N. A. et al. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J. Cell. Biochem. 99, 1616\u20131627 (2006).","journal-title":"J. Cell. Biochem."},{"key":"BFnrgastro2017101_CR60","first-page":"3387","volume":"62","author":"KM Comerford","year":"2002","unstructured":"Comerford, K. M. et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387\u20133394 (2002).","journal-title":"Cancer Res."},{"key":"BFnrgastro2017101_CR61","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1096\/fj.06-6419com","volume":"20","author":"T Kong","year":"2006","unstructured":"Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K. & Colgan, S. P. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242\u20132250 (2006).","journal-title":"FASEB J."},{"key":"BFnrgastro2017101_CR62","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1084\/jem.20050177","volume":"202","author":"HK Eltzschig","year":"2005","unstructured":"Eltzschig, H. K. et al. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202, 1493\u20131505 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2017101_CR63","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/j.gastro.2008.10.037","volume":"136","author":"JC Morote-Garcia","year":"2009","unstructured":"Morote-Garcia, J. C., Rosenberger, P., Nivillac, N. M., Coe, I. R. & Eltzschig, H. K. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 136, 607\u2013618 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR64","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/mi.2015.22","volume":"8","author":"CM Aherne","year":"2015","unstructured":"Aherne, C. M. et al. Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis. Mucosal Immunol. 8, 1324\u20131338 (2015).","journal-title":"Mucosal Immunol."},{"key":"BFnrgastro2017101_CR65","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.4049\/jimmunol.0801324","volume":"182","author":"JS Frick","year":"2009","unstructured":"Frick, J. S. et al. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. J. Immunol. 182, 4957\u20134964 (2009).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR66","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17, 662\u2013671 (2015).","journal-title":"Cell Host Microbe"},{"key":"BFnrgastro2017101_CR67","doi-asserted-by":"publisher","first-page":"19820","DOI":"10.1073\/pnas.1302840110","volume":"110","author":"LE Glover","year":"2013","unstructured":"Glover, L. E. et al. Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis. Proc. Natl Acad. Sci. USA 110, 19820\u201319825 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR68","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.4049\/jimmunol.1002541","volume":"185","author":"P Hindryckx","year":"2010","unstructured":"Hindryckx, P. et al. Hydroxylase inhibition abrogates TNF-\u03b1-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD. J. Immunol. 185, 6306\u20136316 (2010).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR69","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/mi.2013.6","volume":"6","author":"CJ Kelly","year":"2013","unstructured":"Kelly, C. J. et al. Fundamental role for HIF-1\u03b1 in constitutive expression of human \u03b2 defensin-1. Mucosal Immunol. 6, 1110\u20131118 (2013).","journal-title":"Mucosal Immunol."},{"key":"BFnrgastro2017101_CR70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.1683","volume":"10","author":"P Rosenberger","year":"2009","unstructured":"Rosenberger, P. et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10, 195\u2013202 (2009).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2017101_CR71","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1096\/fj.04-3251com","volume":"19","author":"NA Louis","year":"2005","unstructured":"Louis, N. A., Hamilton, K. E., Kong, T. & Colgan, S. P. HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils. FASEB J. 19, 950\u2013959 (2005).","journal-title":"FASEB J."},{"key":"BFnrgastro2017101_CR72","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.20040915","volume":"200","author":"LF Thompson","year":"2004","unstructured":"Thompson, L. F. et al. Crucial role for ecto-5\u2032-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395\u20131405 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2017101_CR73","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1084\/jem.20030891","volume":"198","author":"HK Eltzschig","year":"2003","unstructured":"Eltzschig, H. K. et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783\u2013796 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2017101_CR74","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1053\/j.gastro.2008.03.009","volume":"134","author":"YM Shah","year":"2008","unstructured":"Shah, Y. M. et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134, 2036\u20132048.e3 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR75","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2013.07.010","volume":"145","author":"X Xue","year":"2013","unstructured":"Xue, X. et al. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. Gastroenterology 145, 831\u2013841 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR76","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1128\/MCB.00324-14","volume":"34","author":"L Xie","year":"2014","unstructured":"Xie, L. et al. Hypoxia-inducible factor\/MAZ-dependent induction of caveolin-1 regulates colon permeability through suppression of occludin, leading to hypoxia-induced inflammation. Mol. Cell. Biol. 34, 3013\u20133023 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR77","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1091\/mbc.E14-07-1194","volume":"26","author":"BJ Saeedi","year":"2015","unstructured":"Saeedi, B. J. et al. HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity. Mol. Biol. Cell 26, 2252\u20132262 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrgastro2017101_CR78","doi-asserted-by":"publisher","first-page":"7480","DOI":"10.1038\/sj.onc.1210566","volume":"26","author":"A Le Bras","year":"2007","unstructured":"Le Bras, A. et al. HIF-2\u03b1 specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 26, 7480\u20137489 (2007).","journal-title":"Oncogene"},{"key":"BFnrgastro2017101_CR79","doi-asserted-by":"publisher","first-page":"46230","DOI":"10.1074\/jbc.M305420200","volume":"278","author":"F Coulet","year":"2003","unstructured":"Coulet, F., Nadaud, S., Agrapart, M. & Soubrier, F. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J. Biol. Chem. 278, 46230\u201346240 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR80","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/00365520510015539","volume":"40","author":"K Palatka","year":"2005","unstructured":"Palatka, K. et al. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease. Scand. J. Gastroenterol. 40, 670\u2013680 (2005).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2017101_CR81","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0016-5085(03)00699-1","volume":"125","author":"OA Hatoum","year":"2003","unstructured":"Hatoum, O. A., Binion, D. G., Otterson, M. F. & Gutterman, D. D. Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. Gastroenterology 125, 58\u201369 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR82","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1074\/jbc.M112.442939","volume":"288","author":"DM Gilkes","year":"2013","unstructured":"Gilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D. & Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J. Biol. Chem. 288, 10819\u201310829 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR83","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-394307-1.00003-5","volume":"296","author":"Z Lokmic","year":"2012","unstructured":"Lokmic, Z., Musyoka, J., Hewitson, T. D. & Darby, I. A. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int. Rev. Cell. Mol. Biol. 296, 139\u2013185 (2012).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"BFnrgastro2017101_CR84","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1164\/rccm.201201-0084OC","volume":"186","author":"RM Kottmann","year":"2012","unstructured":"Kottmann, R. M. et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-\u03b2. Am. J. Respir. Crit. Care Med. 186, 740\u2013751 (2012).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrgastro2017101_CR85","doi-asserted-by":"publisher","first-page":"24171","DOI":"10.1074\/jbc.M604507200","volume":"281","author":"S McMahon","year":"2006","unstructured":"McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E. & Dubois, C. M. Transforming growth factor \u03b21 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem. 281, 24171\u201324181 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR86","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4161\/cc.8.9.8306","volume":"8","author":"T Hackenbeck","year":"2009","unstructured":"Hackenbeck, T. et al. HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia. Cell Cycle 8, 1386\u20131395 (2009).","journal-title":"Cell Cycle"},{"key":"BFnrgastro2017101_CR87","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer, T. et al. HIF-1\u03b1 is essential for myeloid cell-mediated inflammation. Cell 112, 645\u2013657 (2003).","journal-title":"Cell"},{"key":"BFnrgastro2017101_CR88","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1172\/JCI23865","volume":"115","author":"C Peyssonnaux","year":"2005","unstructured":"Peyssonnaux, C. et al. HIF-1\u03b1 expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115, 1806\u20131815 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR89","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1182\/blood-2013-05-500207","volume":"123","author":"AA Thompson","year":"2014","unstructured":"Thompson, A. A. et al. Hypoxia-inducible factor 2\u03b1 regulates key neutrophil functions in humans, mice, and zebrafish. Blood 123, 366\u2013376 (2014).","journal-title":"Blood"},{"key":"BFnrgastro2017101_CR90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/jcm5120118","volume":"5","author":"O Wera","year":"2016","unstructured":"Wera, O., Lancellotti, P. & Oury, C. The dual role of neutrophils in inflammatory bowel diseases. J. Clin. Med. 5, 118 (2016).","journal-title":"J. Clin. Med."},{"key":"BFnrgastro2017101_CR91","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677\u2013686 (2004).","journal-title":"Trends Immunol."},{"key":"BFnrgastro2017101_CR92","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/MOG.0b013e32833d4b71","volume":"26","author":"SZ Sheikh","year":"2010","unstructured":"Sheikh, S. Z. & Plevy, S. E. The role of the macrophage in sentinel responses in intestinal immunity. Curr. Opin. Gastroenterol. 26, 578\u2013582 (2010).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"BFnrgastro2017101_CR93","doi-asserted-by":"publisher","first-page":"275","DOI":"10.14348\/molcells.2014.2374","volume":"37","author":"AC Labonte","year":"2014","unstructured":"Labonte, A. C., Tosello-Trampont, A. C. & Hahn, Y. S. The role of macrophage polarization in infectious and inflammatory diseases. Mol. Cells 37, 275\u2013285 (2014).","journal-title":"Mol. Cells"},{"key":"BFnrgastro2017101_CR94","first-page":"420","volume":"5","author":"S Galvan-Pena","year":"2014","unstructured":"Galvan-Pena, S. & O'Neill, L. A. Metabolic reprograming in macrophage polarization. Front. Immunol. 5, 420 (2014).","journal-title":"Front. Immunol."},{"key":"BFnrgastro2017101_CR95","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B. & Simon, M. C. Differential roles of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) and HIF-2\u03b1 in hypoxic gene regulation. Mol. Cell. Biol. 23, 9361\u20139374 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR96","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2567.2009.03203.x","volume":"129","author":"SY Kim","year":"2010","unstructured":"Kim, S. Y. et al. Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 129, 516\u2013524 (2010).","journal-title":"Immunology"},{"key":"BFnrgastro2017101_CR97","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.1881410","volume":"24","author":"N Takeda","year":"2010","unstructured":"Takeda, N. et al. Differential activation and antagonistic function of HIF-\u03b1 isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24, 491\u2013501 (2010).","journal-title":"Genes Dev."},{"key":"BFnrgastro2017101_CR98","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1172\/JCI39506","volume":"120","author":"HZ Imtiyaz","year":"2010","unstructured":"Imtiyaz, H. Z. et al. Hypoxia-inducible factor 2\u03b1 regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest. 120, 2699\u20132714 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR99","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1515\/hsz-2012-0320","volume":"394","author":"R Wobben","year":"2013","unstructured":"Wobben, R. et al. Role of hypoxia inducible factor-1\u03b1 for interferon synthesis in mouse dendritic cells. Biol. Chem. 394, 495\u2013505 (2013).","journal-title":"Biol. Chem."},{"key":"BFnrgastro2017101_CR100","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jcp.22761","volume":"227","author":"A Naldini","year":"2012","unstructured":"Naldini, A. et al. Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1\u03b1 and lipopolysaccharide. J. Cell. Physiol. 227, 587\u2013595 (2012).","journal-title":"J. Cell. Physiol."},{"key":"BFnrgastro2017101_CR101","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/mi.2015.67","volume":"9","author":"K Fluck","year":"2016","unstructured":"Fluck, K., Breves, G., Fandrey, J. & Winning, S. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis. Mucosal. Immunol. 9, 379\u2013390 (2016).","journal-title":"Mucosal. Immunol."},{"key":"BFnrgastro2017101_CR102","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00109-012-0986-9","volume":"91","author":"LE Crotty Alexander","year":"2013","unstructured":"Crotty Alexander, L. E. et al. Myeloid cell HIF-1\u03b1 regulates asthma airway resistance and eosinophil function. J. Mol. Med. (Berl.) 91, 637\u2013644 (2013).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrgastro2017101_CR103","doi-asserted-by":"publisher","first-page":"e34259","DOI":"10.1371\/journal.pone.0034259","volume":"7","author":"VV Sumbayev","year":"2012","unstructured":"Sumbayev, V. V., Yasinska, I., Oniku, A. E., Streatfield, C. L. & Gibbs, B. F. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PLoS ONE 7, e34259 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2017101_CR104","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1128\/MCB.24.20.9038-9047.2004","volume":"24","author":"MP Biju","year":"2004","unstructured":"Biju, M. P. et al. Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol. Cell. Biol. 24, 9038\u20139047 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR105","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4049\/jimmunol.1402552","volume":"195","author":"H Shehade","year":"2015","unstructured":"Shehade, H., Acolty, V., Moser, M. & Oldenhove, G. Cutting edge: hypoxia-inducible factor 1 negatively regulates Th1 function. J. Immunol. 195, 1372\u20131376 (2015).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR106","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/eji.200838318","volume":"38","author":"J Ben-Shoshan","year":"2008","unstructured":"Ben-Shoshan, J., Maysel-Auslender, S., Mor, A., Keren, G. & George, J. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1\u03b1. Eur. J. Immunol. 38, 2412\u20132418 (2008).","journal-title":"Eur. J. Immunol."},{"key":"BFnrgastro2017101_CR107","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E. V. et al. Control of TH17\/Treg balance by hypoxia-inducible factor 1. Cell 146, 772\u2013784 (2011).","journal-title":"Cell"},{"key":"BFnrgastro2017101_CR108","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1189\/jlb.1011518","volume":"91","author":"M Higashiyama","year":"2012","unstructured":"Higashiyama, M. et al. HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis. J. Leukoc. Biol. 91, 901\u2013909 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrgastro2017101_CR109","doi-asserted-by":"publisher","first-page":"E2784","DOI":"10.1073\/pnas.1202366109","volume":"109","author":"ET Clambey","year":"2012","unstructured":"Clambey, E. T. et al. Hypoxia-inducible factor-1\u03b1-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl Acad. Sci. USA 109, E2784\u2013E2793 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR110","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1681\/ASN.2014121248","volume":"27","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Hypoxia-inducible factor-2\u03b1 limits natural killer T cell cytotoxicity in renal ischemia\/reperfusion injury. J. Am. Soc. Nephrol. 27, 92\u2013106 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrgastro2017101_CR111","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1073\/pnas.052706699","volume":"99","author":"H Kojima","year":"2002","unstructured":"Kojima, H. et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1\u03b1-deficient chimeric mice. Proc. Natl Acad. Sci. USA 99, 2170\u20132174 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR112","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/MCB.23.1.359-369.2003","volume":"23","author":"N Goda","year":"2003","unstructured":"Goda, N. et al. Hypoxia-inducible factor 1\u03b1 is essential for cell cycle arrest during hypoxia. Mol. Cell. Biol. 23, 359\u2013369 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR113","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature19334","volume":"537","author":"SH Cho","year":"2016","unstructured":"Cho, S. H. et al. Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature 537, 234\u2013238 (2016).","journal-title":"Nature"},{"key":"BFnrgastro2017101_CR114","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden, M. S. & Ghosh, S. NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26, 203\u2013234 (2012).","journal-title":"Genes Dev."},{"key":"BFnrgastro2017101_CR115","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm0996-998","volume":"2","author":"MF Neurath","year":"1996","unstructured":"Neurath, M. F., Pettersson, S., Meyer zum Buschenfelde, K. H. & Strober, W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-\u03baB abrogates established experimental colitis in mice. Nat. Med. 2, 998\u20131004 (1996).","journal-title":"Nat. Med."},{"key":"BFnrgastro2017101_CR116","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00011-003-1206-4","volume":"52","author":"JF MacMaster","year":"2003","unstructured":"MacMaster, J. F. et al. An inhibitor of I\u03baB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm. Res. 52, 508\u2013511 (2003).","journal-title":"Inflamm. Res."},{"key":"BFnrgastro2017101_CR117","doi-asserted-by":"publisher","first-page":"15058","DOI":"10.1073\/pnas.0808216105","volume":"105","author":"L Eckmann","year":"2008","unstructured":"Eckmann, L. et al. Opposing functions of IKK\u03b2 during acute and chronic intestinal inflammation. Proc. Natl Acad. Sci. USA 105, 15058\u201315063 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR118","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1038\/sj.onc.1209943","volume":"25","author":"MS Hayden","year":"2006","unstructured":"Hayden, M. S., West, A. P. & Ghosh, S. NF-\u03baB and the immune response. Oncogene 25, 6758\u20136780 (2006).","journal-title":"Oncogene"},{"key":"BFnrgastro2017101_CR119","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/nm1201-1291","volume":"7","author":"T Lawrence","year":"2001","unstructured":"Lawrence, T., Gilroy, D. W., Colville-Nash, P. R. & Willoughby, D. A. Possible new role for NF-\u03baB in the resolution of inflammation. Nat. Med. 7, 1291\u20131297 (2001).","journal-title":"Nat. Med."},{"key":"BFnrgastro2017101_CR120","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2007.07.009","volume":"130","author":"FR Greten","year":"2007","unstructured":"Greten, F. R. et al. NF-\u03baB is a negative regulator of IL-1\u03b2 secretion as revealed by genetic and pharmacological inhibition of IKK\u03b2. Cell 130, 918\u2013931 (2007).","journal-title":"Cell"},{"key":"BFnrgastro2017101_CR121","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.4049\/jimmunol.166.3.1443","volume":"166","author":"S Erdman","year":"2001","unstructured":"Erdman, S., Fox, J. G., Dangler, C. A., Feldman, D. & Horwitz, B. H. Typhlocolitis in NF-\u03baB-deficient mice. J. Immunol. 166, 1443\u20131447 (2001).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR122","doi-asserted-by":"publisher","first-page":"7332","DOI":"10.4049\/jimmunol.177.10.7332","volume":"177","author":"MF Tomczak","year":"2006","unstructured":"Tomczak, M. F. et al. Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50\/p105 subunit of NF-\u03baB. J. Immunol. 177, 7332\u20137339 (2006).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR123","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature05698","volume":"446","author":"A Nenci","year":"2007","unstructured":"Nenci, A. et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557\u2013561 (2007).","journal-title":"Nature"},{"key":"BFnrgastro2017101_CR124","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1053\/j.gastro.2010.06.068","volume":"139","author":"MM Tambuwala","year":"2010","unstructured":"Tambuwala, M. M. et al. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139, 2093\u20132101 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR125","doi-asserted-by":"publisher","first-page":"20580","DOI":"10.1074\/jbc.M115.653584","volume":"290","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. PHD3 stabilizes the tight junction protein occludin and protects intestinal epithelial barrier function. J. Biol. Chem. 290, 20580\u201320589 (2015).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2017101_CR126","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1128\/MCB.00609-13","volume":"33","author":"J Kalucka","year":"2013","unstructured":"Kalucka, J. et al. Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice. Mol. Cell. Biol. 33, 3426\u20133438 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR127","doi-asserted-by":"crossref","first-page":"54317","DOI":"10.18632\/oncotarget.11104","volume":"7","author":"Y Fang","year":"2016","unstructured":"Fang, Y., Zhang, H., Zhong, Y. & Ding, X. Prolyl hydroxylase 2 (PHD2) inhibition protects human renal epithelial cells and mice kidney from hypoxia injury. Oncotarget 7, 54317\u201354328 (2016).","journal-title":"Oncotarget"},{"key":"BFnrgastro2017101_CR128","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.HYP.0000251360.40838.0f","volume":"49","author":"K Takeda","year":"2007","unstructured":"Takeda, K. & Fong, G. H. Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation. Hypertension 49, 178\u2013184 (2007).","journal-title":"Hypertension"},{"key":"BFnrgastro2017101_CR129","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","volume":"136","author":"M Mazzone","year":"2009","unstructured":"Mazzone, M. et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839\u2013851 (2009).","journal-title":"Cell"},{"key":"BFnrgastro2017101_CR130","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ccr.2012.06.028","volume":"22","author":"R Leite de Oliveira","year":"2012","unstructured":"Leite de Oliveira, R. et al. Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 22, 263\u2013277 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrgastro2017101_CR131","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.116.021494","volume":"133","author":"Z Dai","year":"2016","unstructured":"Dai, Z., Li, M., Wharton, J., Zhu, M. M. & Zhao, Y. Y. Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2\u03b1. Circulation 133, 2447\u20132458 (2016).","journal-title":"Circulation"},{"key":"BFnrgastro2017101_CR132","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1128\/MCB.01055-15","volume":"36","author":"PP Kapitsinou","year":"2016","unstructured":"Kapitsinou, P. P. et al. Theendothelial prolyl-4-hydroxylase domain 2\/hypoxia-inducible factor 2 axis regulates pulmonary artery pressure in mice. Mol. Cell. Biol. 36, 1584\u20131594 (2016).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR133","doi-asserted-by":"crossref","first-page":"58848","DOI":"10.18632\/oncotarget.11585","volume":"7","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling. Oncotarget 7, 58848\u201358861 (2016).","journal-title":"Oncotarget"},{"key":"BFnrgastro2017101_CR134","doi-asserted-by":"publisher","unstructured":"Wang, S. et al. Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice. J. Cell. Mol. Med. http:\/\/dx.doi.org\/10.1111\/jcmm.13117 (2017).","DOI":"10.1111\/jcmm.13117"},{"key":"BFnrgastro2017101_CR135","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/path.4861","volume":"241","author":"S Van Welden","year":"2016","unstructured":"Van Welden, S. et al. Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis. J. Pathol. 241, 547\u2013558 (2016).","journal-title":"J. Pathol."},{"key":"BFnrgastro2017101_CR136","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/mt.2008.90","volume":"16","author":"S Wu","year":"2008","unstructured":"Wu, S. et al. Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene. Mol. Ther. 16, 1227\u20131234 (2008).","journal-title":"Mol. Ther."},{"key":"BFnrgastro2017101_CR137","doi-asserted-by":"publisher","first-page":"G1076","DOI":"10.1152\/ajpgi.00229.2016","volume":"311","author":"MC Manresa","year":"2016","unstructured":"Manresa, M. C. et al. Hydroxylases regulate intestinal fibrosis through the suppression of ERK mediated TGF-\u03b21 signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G1076\u2013G1090 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2017101_CR138","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1172\/JCI43273","volume":"121","author":"SR Walmsley","year":"2011","unstructured":"Walmsley, S. R. et al. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. J. Clin. Invest. 121, 1053\u20131063 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR139","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/ATVBAHA.109.196071","volume":"29","author":"K Takeda","year":"2009","unstructured":"Takeda, K. et al. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-\u03b1 expression. Arterioscler. Thromb. Vasc. Biol. 29, 2132\u20132137 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrgastro2017101_CR140","doi-asserted-by":"publisher","first-page":"e000178","DOI":"10.1161\/JAHA.113.000178","volume":"2","author":"J Ikeda","year":"2013","unstructured":"Ikeda, J. et al. Deletion of Phd2 in myeloid lineage attenuates hypertensive cardiovascular remodeling. J. Am. Heart Assoc. 2, e000178 (2013).","journal-title":"J. Am. Heart Assoc."},{"key":"BFnrgastro2017101_CR141","doi-asserted-by":"publisher","first-page":"e00236-16","DOI":"10.1128\/MCB.00236-16","volume":"37","author":"A Guentsch","year":"2017","unstructured":"Guentsch, A. et al. PHD2 is a regulator for glycolytic reprogramming in macrophages. Mol. Cell. Biol. 37, e00236-16 (2017).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrgastro2017101_CR142","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.4049\/jimmunol.1201064","volume":"189","author":"MM Escribese","year":"2012","unstructured":"Escribese, M. M. et al. The prolyl hydroxylase PHD3 identifies proinflammatory macrophages and its expression is regulated by activin A. J. Immunol. 189, 1946\u20131954 (2012).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR143","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.4049\/jimmunol.1103471","volume":"189","author":"J Kiss","year":"2012","unstructured":"Kiss, J. et al. Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. J. Immunol. 189, 1955\u20131965 (2012).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR144","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1189\/jlb.2HI1013-533R","volume":"96","author":"L Swain","year":"2014","unstructured":"Swain, L. et al. Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions. J. Leukoc. Biol. 96, 365\u2013375 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrgastro2017101_CR145","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/ijc.28409","volume":"134","author":"S Mamlouk","year":"2014","unstructured":"Mamlouk, S. et al. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. Int. J. Cancer 134, 849\u2013858 (2014).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2017101_CR146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molimm.2016.06.003","volume":"76","author":"Y Singh","year":"2016","unstructured":"Singh, Y. et al. Prolyl hydroxylase 3 (PHD3) expression augments the development of regulatory T cells. Mol. Immunol. 76, 7\u201312 (2016).","journal-title":"Mol. Immunol."},{"key":"BFnrgastro2017101_CR147","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","volume":"166","author":"D Clever","year":"2016","unstructured":"Clever, D. et al. Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche. Cell 166, 1117\u20131131.e14 (2016).","journal-title":"Cell"},{"key":"BFnrgastro2017101_CR148","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.gastro.2007.10.012","volume":"134","author":"EP Cummins","year":"2008","unstructured":"Cummins, E. P. et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134, 156\u2013165 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR149","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2007.09.033","volume":"134","author":"A Robinson","year":"2008","unstructured":"Robinson, A. et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145\u2013155 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR150","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrd2761","volume":"8","author":"P Fraisl","year":"2009","unstructured":"Fraisl, P., Aragones, J. & Carmeliet, P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat. Rev. Drug Discov. 8, 139\u2013152 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrgastro2017101_CR151","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/mi.2013.29","volume":"7","author":"S Keely","year":"2014","unstructured":"Keely, S. et al. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal. Immunol. 7, 114\u2013123 (2014).","journal-title":"Mucosal. Immunol."},{"key":"BFnrgastro2017101_CR152","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MIB.0000000000000277","volume":"21","author":"E Marks","year":"2015","unstructured":"Marks, E. et al. Oral delivery of prolyl hydroxylase inhibitor: AKB-4924 promotes localized mucosal healing in a mouse model of colitis. Inflamm. Bowel. Dis. 21, 267\u2013275 (2015).","journal-title":"Inflamm. Bowel. Dis."},{"key":"BFnrgastro2017101_CR153","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/CEG.S51923","volume":"7","author":"R Gupta","year":"2014","unstructured":"Gupta, R. et al. Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis. Clin. Exp. Gastroenterol. 7, 13\u201323 (2014).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"BFnrgastro2017101_CR154","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000341870","volume":"36","author":"P Jamadarkhana","year":"2012","unstructured":"Jamadarkhana, P. et al. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury. Am. J. Nephrol. 36, 208\u2013218 (2012).","journal-title":"Am. J. Nephrol."},{"key":"BFnrgastro2017101_CR155","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejphar.2014.11.030","volume":"747","author":"S Jeong","year":"2015","unstructured":"Jeong, S. et al. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity. Eur. J. Pharmacol. 747, 114\u2013122 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrgastro2017101_CR156","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.4049\/jimmunol.0903617","volume":"186","author":"ML Hart","year":"2011","unstructured":"Hart, M. L. et al. Hypoxia-inducible factor-1\u03b1-dependent protection from intestinal ischemia\/reperfusion injury involves ecto-5\u2032-nucleotidase (CD73) and the A2B adenosine receptor. J. Immunol. 186, 4367\u20134374 (2011).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR157","doi-asserted-by":"publisher","first-page":"236ra64","DOI":"10.1126\/scitranslmed.3008523","volume":"6","author":"CM Taniguchi","year":"2014","unstructured":"Taniguchi, C. M. et al. PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2. Sci. Transl Med. 6, 236ra64 (2014).","journal-title":"Sci. Transl Med."},{"key":"BFnrgastro2017101_CR158","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.gastro.2010.03.045","volume":"139","author":"SA Hirota","year":"2010","unstructured":"Hirota, S. A. et al. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology 139, 259\u2013269.e3 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR159","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.kint.2016.07.019","volume":"90","author":"PE Pergola","year":"2016","unstructured":"Pergola, P. E., Spinowitz, B. S., Hartman, C. S., Maroni, B. J. & Haase, V. H. Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease. Kidney Int. 90, 1115\u20131122 (2016).","journal-title":"Kidney Int."},{"key":"BFnrgastro2017101_CR160","doi-asserted-by":"publisher","first-page":"982","DOI":"10.2215\/CJN.06890615","volume":"11","author":"R Provenzano","year":"2016","unstructured":"Provenzano, R. et al. Oral hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD. Clin. J. Am. Soc. Nephrol. 11, 982\u2013991 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrgastro2017101_CR161","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1053\/j.ajkd.2015.11.021","volume":"67","author":"RA Brigandi","year":"2016","unstructured":"Brigandi, R. A. et al. A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: A 28-day, phase 2A randomized trial. Am. J. Kidney Dis. 67, 861\u2013871 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrgastro2017101_CR162","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.4049\/jimmunol.1103817","volume":"189","author":"JM Roda","year":"2012","unstructured":"Roda, J. M. et al. Stabilization of HIF-2\u03b1 induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model. J. Immunol. 189, 3168\u20133177 (2012).","journal-title":"J. Immunol."},{"key":"BFnrgastro2017101_CR163","first-page":"4721","volume":"23","author":"T Shibaji","year":"2003","unstructured":"Shibaji, T. et al. Prognostic significance of HIF-1\u03b1 overexpression in human pancreatic cancer. Anticancer Res. 23, 4721\u20134727 (2003).","journal-title":"Anticancer Res."},{"key":"BFnrgastro2017101_CR164","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1158\/1078-0432.CCR-0946-03","volume":"10","author":"H Yoshimura","year":"2004","unstructured":"Yoshimura, H. et al. Prognostic impact of hypoxia-inducible factors 1\u03b1 and 2\u03b1 in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin. Cancer Res. 10, 8554\u20138560 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2017101_CR165","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","volume":"29","author":"B Allard","year":"2016","unstructured":"Allard, B., Beavis, P. A., Darcy, P. K. & Stagg, J. Immunosuppressive activities of adenosine in cancer. Curr. Opin. Pharmacol. 29, 7\u201316 (2016).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrgastro2017101_CR166","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trecan.2016.01.003","volume":"2","author":"L Antonioli","year":"2016","unstructured":"Antonioli, L., Yegutkin, G. G., Pacher, P., Blandizzi, C. & Hasko, G. Anti-CD73 in cancer immunotherapy: awakening new opportunities. Trends Cancer 2, 95\u2013109 (2016).","journal-title":"Trends Cancer"},{"key":"BFnrgastro2017101_CR167","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1073\/pnas.0908801107","volume":"107","author":"J Stagg","year":"2010","unstructured":"Stagg, J. et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl Acad. Sci. USA 107, 1547\u20131552 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR168","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta, A. et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl Acad. Sci. USA 103, 13132\u201313137 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR169","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","volume":"19","author":"B Allard","year":"2013","unstructured":"Allard, B., Pommey, S., Smyth, M. J. & Stagg, J. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Clin. Cancer Res. 19, 5626\u20135635 (2013).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2017101_CR170","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","volume":"3","author":"PA Beavis","year":"2015","unstructured":"Beavis, P. A. et al. Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced antitumor T-cell responses. Cancer Immunol. Res. 3, 506\u2013517 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"BFnrgastro2017101_CR171","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02503774 (2017)."},{"key":"BFnrgastro2017101_CR172","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02403193 (2017)."},{"key":"BFnrgastro2017101_CR173","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-11-3836","volume":"72","author":"X Xue","year":"2012","unstructured":"Xue, X. et al. Hypoxia-inducible factor-2\u03b1 activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res. 72, 2285\u20132293 (2012).","journal-title":"Cancer Res."},{"key":"BFnrgastro2017101_CR174","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","volume":"95","author":"EJ Yeo","year":"2003","unstructured":"Yeo, E. J. et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl Cancer Inst. 95, 516\u2013525 (2003).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2017101_CR175","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2007.03.026","volume":"255","author":"DH Shin","year":"2007","unstructured":"Shin, D. H. et al. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading. Cancer Lett. 255, 107\u2013116 (2007).","journal-title":"Cancer Lett."},{"key":"BFnrgastro2017101_CR176","doi-asserted-by":"publisher","first-page":"G187","DOI":"10.1152\/ajpgi.00112.2014","volume":"307","author":"X Xue","year":"2014","unstructured":"Xue, X., Ramakrishnan, S. K. & Shah, Y. M. Activation of HIF-1\u03b1 does not increase intestinal tumorigenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G187\u2013G195 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2017101_CR177","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00281-009-0161-8","volume":"31","author":"MJ Waldner","year":"2009","unstructured":"Waldner, M. J. & Neurath, M. F. Colitis-associated cancer: the role of T cells in tumor development. Semin. Immunopathol. 31, 249\u2013256 (2009).","journal-title":"Semin. Immunopathol."},{"key":"BFnrgastro2017101_CR178","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","volume":"145","author":"L Beaugerie","year":"2013","unstructured":"Beaugerie, L. et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 145, 166\u2013178 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017101_CR179","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.MIB.0000442728.74340.fd","volume":"20","author":"N Filmann","year":"2014","unstructured":"Filmann, N. et al. Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm. Bowel Dis. 20, 936\u2013945 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017101_CR180","doi-asserted-by":"publisher","first-page":"e34520","DOI":"10.1371\/journal.pone.0034520","volume":"7","author":"S Kulnigg-Dabsch","year":"2012","unstructured":"Kulnigg-Dabsch, S., Evstatiev, R., Dejaco, C. & Gasche, C. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PLoS ONE 7, e34520 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2017101_CR181","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1097\/MIB.0b013e318281f4db","volume":"19","author":"S Kulnigg-Dabsch","year":"2013","unstructured":"Kulnigg-Dabsch, S. et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflamm. Bowel Dis. 19, 1609\u20131616 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017101_CR182","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/ibd.20896","volume":"15","author":"H Yoshida","year":"2009","unstructured":"Yoshida, H. & Granger, D. N. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm. Bowel Dis. 15, 1245\u20131255 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017101_CR183","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2559.1992.tb00360.x","volume":"21","author":"AP Dhillon","year":"1992","unstructured":"Dhillon, A. P. et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 21, 127\u2013133 (1992).","journal-title":"Histopathology"},{"key":"BFnrgastro2017101_CR184","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2003.025411","volume":"53","author":"W Miehsler","year":"2004","unstructured":"Miehsler, W. et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53, 542\u2013548 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2017101_CR185","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins, D. F. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117, 3810\u20133820 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2017101_CR186","doi-asserted-by":"publisher","first-page":"G582","DOI":"10.1152\/ajpgi.90368.2008","volume":"296","author":"JO Moon","year":"2009","unstructured":"Moon, J. O., Welch, T. P., Gonzalez, F. J. & Copple, B. L. Reduced liver fibrosis in hypoxia-inducible factor-1\u03b1-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G582\u2013G592 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2017101_CR187","doi-asserted-by":"publisher","first-page":"e00061","DOI":"10.1002\/prp2.61","volume":"2","author":"S Roychowdhury","year":"2014","unstructured":"Roychowdhury, S., Chiang, D. J., McMullen, M. R. & Nagy, L. E. Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1\u03b1. Pharmacol. Res. Perspect. 2, e00061 (2014).","journal-title":"Pharmacol. Res. Perspect."},{"key":"BFnrgastro2017101_CR188","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1124\/jpet.111.189340","volume":"341","author":"BL Copple","year":"2012","unstructured":"Copple, B. L., Kaska, S. & Wentling, C. Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice. J. Pharmacol. Exp. Ther. 341, 307\u2013316 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrgastro2017101_CR189","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes, J. et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm. Bowel Dis. 8, 244\u2013250 (2002).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017101_CR190","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00109-012-0882-3","volume":"90","author":"CY Okumura","year":"2012","unstructured":"Okumura, C. Y. et al. A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. J. Mol. Med. (Berl.) 90, 1079\u20131089 (2012).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrgastro2017101_CR191","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.sbi.2010.08.006","volume":"20","author":"MA McDonough","year":"2010","unstructured":"McDonough, M. A., Loenarz, C., Chowdhury, R., Clifton, I. J. & Schofield, C. J. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin. Struct. Biol. 20, 659\u2013672 (2010).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnrgastro2017101_CR192","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tibs.2010.07.002","volume":"36","author":"C Loenarz","year":"2011","unstructured":"Loenarz, C. & Schofield, C. J. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 36, 7\u201318 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"BFnrgastro2017101_CR193","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1196\/annals.1293.013","volume":"1011","author":"YS Yoon","year":"2004","unstructured":"Yoon, Y. S., Cho, H., Lee, J. H. & Yoon, G. Mitochondrial dysfunction via disruption of complex II activity during iron chelation-induced senescence-like growth arrest of Chang cells. Ann. NY Acad. Sci. 1011, 123\u2013132 (2004).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrgastro2017101_CR194","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","volume":"55","author":"P Needleman","year":"1986","unstructured":"Needleman, P., Turk, J., Jakschik, B. A., Morrison, A. R. & Lefkowith, J. B. Arachidonic acid metabolism. Annu. Rev. Biochem. 55, 69\u2013102 (1986).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrgastro2017101_CR195","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2015.09.022","volume":"217","author":"MM Tambuwala","year":"2015","unstructured":"Tambuwala, M. M. et al. Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis. J. Control Release 217, 221\u2013227 (2015).","journal-title":"J. Control Release"},{"key":"BFnrgastro2017101_CR196","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1476-9255-10-36","volume":"10","author":"S Van Welden","year":"2013","unstructured":"Van Welden, S., Laukens, D., Ferdinande, L., De, V. M. & Hindryckx, P. Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn's disease\/infectious colitis and healthy controls. J. Inflamm. (Lond.) 10, 36 (2013).","journal-title":"J. Inflamm. (Lond.)"},{"key":"BFnrgastro2017101_CR197","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cmet.2015.12.007","volume":"23","author":"A Quaegebeur","year":"2016","unstructured":"Quaegebeur, A. et al. Deletion or inhibition of the oxygen sensor PHD1 protects against ischemic stroke via reprogramming of neuronal metabolism. Cell Metab. 23, 280\u2013291 (2016).","journal-title":"Cell Metab."},{"key":"BFnrgastro2017101_CR198","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1242\/jcs.119974","volume":"126","author":"LK Nguyen","year":"2013","unstructured":"Nguyen, L. K. et al. A dynamic model of the hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) network. J. Cell Sci. 126, 1454\u20131463 (2013).","journal-title":"J. Cell Sci."},{"key":"BFnrgastro2017101_CR199","doi-asserted-by":"publisher","first-page":"18490","DOI":"10.1073\/pnas.1309718110","volume":"110","author":"CC Scholz","year":"2013","unstructured":"Scholz, C. C. et al. Regulation of IL-1\u03b2-induced NF-\u03baB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc. Natl Acad. Sci. USA 110, 18490\u201318495 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2017101_CR200","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1006\/cyto.1998.0355","volume":"10","author":"Y Arai","year":"1998","unstructured":"Arai, Y., Takanashi, H., Kitagawa, H. & Okayasu, I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 10, 890\u2013896 (1998).","journal-title":"Cytokine"},{"key":"BFnrgastro2017101_CR201","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02892149 (2017)."},{"key":"BFnrgastro2017101_CR202","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02865850 (2017)."},{"key":"BFnrgastro2017101_CR203","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02680574 (2017)."},{"key":"BFnrgastro2017101_CR204","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02648347 (2017)."},{"key":"BFnrgastro2017101_CR205","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02876835 (2017)."},{"key":"BFnrgastro2017101_CR206","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02879305 (2017)."},{"key":"BFnrgastro2017101_CR207","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02969655 (2017)."},{"key":"BFnrgastro2017101_CR208","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02914262 (2017)."},{"key":"BFnrgastro2017101_CR209","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01750190 (2017)."},{"key":"BFnrgastro2017101_CR210","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02021318 (2016)."},{"key":"BFnrgastro2017101_CR211","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02174627 (2017)."},{"key":"BFnrgastro2017101_CR212","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02652806 (2017)."},{"key":"BFnrgastro2017101_CR213","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02652819 (2017)."},{"key":"BFnrgastro2017101_CR214","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02273726 (2017)."},{"key":"BFnrgastro2017101_CR215","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01887600 (2017)."},{"key":"BFnrgastro2017101_CR216","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02055482 (2017)."},{"key":"BFnrgastro2017101_CR217","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01975818 (2016)."},{"key":"BFnrgastro2017101_CR218","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02064426 (2017)."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrgastro.2017.101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:57:02Z","timestamp":1684454222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2017.101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":218,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFnrgastro2017101"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2017.101","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"assertion":[{"value":"30 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.H. has received consultancy fees from Abbvie, Ferring and Takeda, honoraria for speaking from Abbvie, Chiesi, Falk Pharma, Ferring, Takeda and Vifor Pharma, and an investigator-initiated study grant from Takeda. S.V.W. and A.S. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}